These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 238085)

  • 1. The effect of parenchymal liver disease on the disposition and elimination of sedatives and analgesics.
    Schenker S; Hoyumpa AM; Wilkinson GR
    Med Clin North Am; 1975 Jul; 59(4):887-96. PubMed ID: 238085
    [No Abstract]   [Full Text] [Related]  

  • 2. The disposition and effects of sedatives and analgesics in liver disease.
    Hoyampa AM; Branch RA; Schenker S
    Annu Rev Med; 1978; 29():205-18. PubMed ID: 348033
    [No Abstract]   [Full Text] [Related]  

  • 3. Effects of liver disease and of aging on the disposition and elimination of sedatives.
    Schenker S
    Trans Am Clin Climatol Assoc; 1978; 89():91-9. PubMed ID: 30206
    [No Abstract]   [Full Text] [Related]  

  • 4. Drug disposition and liver disease.
    Wilkinson GR; Schenker S
    Drug Metab Rev; 1975; 4(2):139-75. PubMed ID: 770104
    [No Abstract]   [Full Text] [Related]  

  • 5. Disposition and elimination of minor tranquilizers in the aged and in patients with liver disease.
    Hoyumpa AM
    South Med J; 1978 Aug; 71 Suppl 2():23-8. PubMed ID: 28572
    [No Abstract]   [Full Text] [Related]  

  • 6. The influence of liver diseases on drug disposition.
    Roberts RK; Branch RA; Desmond PV; Schenker S
    Clin Gastroenterol; 1979 Jan; 8(1):105-21. PubMed ID: 369741
    [No Abstract]   [Full Text] [Related]  

  • 7. [Hypnotics and sedatives in liver diseases (summary of session 4)].
    Z Gastroenterol Verh; 1976; (12):203-20. PubMed ID: 73293
    [No Abstract]   [Full Text] [Related]  

  • 8. [Clinical problems in the application of sedatives in patients with chronic liver disease (author's transl)].
    Becker K
    Z Gastroenterol; 1977 Jun; 15(6):356-61. PubMed ID: 888484
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impaired elimination of meperidine in patients with liver disease.
    McHorse TS; Klotz U; Wilkinson G; Schenker S
    Trans Assoc Am Physicians; 1974; 87():281-7. PubMed ID: 4456737
    [No Abstract]   [Full Text] [Related]  

  • 10. The effects of liver and renal dysfunction on the pharmacokinetics of sedatives and analgesics in the critically ill patient.
    Yogaratnam D; Miller MA; Smith BS
    Crit Care Nurs Clin North Am; 2005 Sep; 17(3):245-50. PubMed ID: 16115532
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effects of liver disease and aging on the disposition of diazepam, chlordiazepoxide, oxazepam and lorazepam in man.
    Wilkinson GR
    Acta Psychiatr Scand Suppl; 1978; (274):56-74. PubMed ID: 32740
    [No Abstract]   [Full Text] [Related]  

  • 12. [Drug therapy in liver diseases].
    Zilly W
    Med Klin; 1979 Oct; 74(43):1575-80. PubMed ID: 44540
    [No Abstract]   [Full Text] [Related]  

  • 13. Drug prescribing in hepatobiliary disease.
    Roberts RK; Desmond PV; Schenker S
    Drugs; 1979 Mar; 17(3):198-212. PubMed ID: 378647
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Disposition of diazepam and its major metabolite desmethyldiazepam in patients with liver disease.
    Klotz U; Antonin KH; Brügel H; Bieck PR
    Clin Pharmacol Ther; 1977 Apr; 21(4):430-6. PubMed ID: 321178
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Pharmacokinetics of intravenous narcotics (barbiturates and fentanyl) anesthesia and intensive care in patients with liver and kidney insufficiency].
    Rietbrock I
    Klin Anasthesiol Intensivther; 1981; 23():59-70. PubMed ID: 7339178
    [No Abstract]   [Full Text] [Related]  

  • 16. [Drug therapy in liver diseases: problems in intensive care].
    Follath F
    Schweiz Med Wochenschr; 1986 Apr; 116(17):549-52. PubMed ID: 3715434
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Absorption and clearance of secobarbital, heptabarbital, methaqualone, and ethinamate.
    Clifford JM; Cookson JH; Wickham PE
    Clin Pharmacol Ther; 1974 Aug; 16(2):376-89. PubMed ID: 4604053
    [No Abstract]   [Full Text] [Related]  

  • 18. The effects of age and liver disease on the disposition and elimination of diazepam in adult man.
    Klotz U; Avant GR; Hoyumpa A; Schenker S; Wilkinson GR
    J Clin Invest; 1975 Feb; 55(2):347-59. PubMed ID: 1127104
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Drug disposition in liver disease.
    Fruncillo RJ
    Am Fam Physician; 1982 Dec; 26(6):167-9. PubMed ID: 7148640
    [No Abstract]   [Full Text] [Related]  

  • 20. Drug kinetics and artificial kidneys.
    Gibson TB; Nelson HA
    Clin Pharmacokinet; 1977; 2(6):403-26. PubMed ID: 22417
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.